Status:
UNKNOWN
The Consistency of Cardiac Output Measurements by Different Methods in VA-ECMO Patients
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Extracorporeal Membrane Oxygenation
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Objective： 1. To evaluate the consistency of cardiac output measured by different hemodynamic monitoring methods in patients with VA-ECMO 2. To evaluate whether different hemodynamic monitoring metho...
Detailed Description
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) has been used for profound cardiogenic shock to bridge to decision,ventricular assist devices,or transplant.Close monitoring of cardiac outpu...
Eligibility Criteria
Inclusion
- cardiac surgery
- treatment with VA-ECMO
- mechanical ventilation
- hemodynamic monitoring according to patient's condition (PAC, Flotrac, echocardiography)
Exclusion
- age \< 18
- cardiac arrhythmia
- moderate to severe aortic, mitral and tricuspid regurgitation
- active hemorrhage
- IABP
- spontaneous triggering of the ventilator
Key Trial Info
Start Date :
August 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04102072
Start Date
August 23 2019
End Date
August 1 2024
Last Update
September 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan hospital, Fudan university
Shanghai, China, 200032